首页 › 超重 › 印第安纳州 › Indianapolis
Indianapolis IN 超重临床试验
13项针对 超重的研究正在 Indianapolis及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
招募中3 期
- IU Health - Riley Physicians Endo-Diab, Indianapolis
AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight
招募中3 期
- Midwest Inst For Clin Res, Indianapolis
A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
招募中3 期
- Midwest Inst For Clin Res, Indianapolis
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
招募中3 期
- Riley Hospital for Children, Indianapolis
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
招募中3 期
- Indiana University Health University Hospital, Indianapolis
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
招募中3 期
- Indiana University Health University Hospital, Indianapolis
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
招募中3 期
- DM Clinical Research - Indianapolis, Indianapolis
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
招募中3 期
- AURORA-2 Clinical Site, Indianapolis
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
招募中3 期
- AURORA-1 Clinical Site, Indianapolis
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
招募中2 期
- Investigators Research Group, Brownsburg · 距离 14 英里
A Research Study to Compare Two Different Versions of Injectable Cagrilintide and Placebo in People With Excess Body Weight
招募中3 期
- Midwest Inst For Clin Res, Indianapolis
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
招募中4 期
- Dawes Fretzin Clinical Research Group, LLC, Indianapolis
- The Indiana Clinical Trials Center, PC, Plainfield · 距离 14 英里
Intensive Glycemic Targets in Overweight and Obese Women With Gestational Diabetes
招募中
- Indiana University, Indianapolis
其他城市的 超重试验
- San Antonio, TX33 项研究
- Houston, TX33 项研究
- Chicago, IL28 项研究
- Orlando, FL25 项研究
- Miami, FL23 项研究
- Las Vegas, NV23 项研究
- Dallas, TX20 项研究
- Atlanta, GA20 项研究
- New York City, NY19 项研究
- Jacksonville, FL19 项研究
- Washington, DC19 项研究
- Austin, TX18 项研究
Indianapolis的其他研究
- 非小细胞肺癌32 项研究
- 癌症（所有类型）25 项研究
- 心力衰竭23 项研究
- 肥胖症20 项研究
- 乳腺癌20 项研究
- 转移性癌症19 项研究
- 结直肠癌18 项研究
- 卵巢癌17 项研究
- 心血管疾病16 项研究
- 肺癌16 项研究
- 子宫内膜癌15 项研究
- 阿尔茨海默病14 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月1日。每项研究自行设定入选标准，由研究团队决定谁能参与。